Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist

Published:2023-02-28 Issue:3 Volume:47 Page:432-434
ISSN:2993-7175
Container-title:Alcohol: Clinical and Experimental Research
language:en
Short-container-title:Alcohol: Clinical and Experimental Research

Author:

Haass‐Koffler Carolina L.¹²³⁴^ORCID

Affiliation:

1. Department of Psychiatry and Human Behavior, Warren Alpert Medical School Brown University Providence Rhode Island USA

2. Department of Behavioral and Social Sciences, School of Public Health Brown University Providence Rhode Island USA

3. Center for Alcohol and Addiction Studies Brown University Providence Rhode Island USA

4. Carney Institute for Brain Science Brown University Providence Rhode Island USA

Funder

National Institute of General Medical Sciences

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acer.15014

Reference19 articles.

1. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology

2. The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems

3. Prazosin Effects on Stress- and Cue-Induced Craving and Stress Response in Alcohol-Dependent Individuals: Preliminary Findings

4. The Role of Stress, Trauma, and Negative Affect in the Development of Alcohol Misuse and Alcohol Use Disorders in Women

5. Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing drugs for treatment of alcohol use disorder;International Review of Neurobiology;2024

2. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy;Journal of Psychopharmacology;2023-11-27

3. A Phase 3 Randomized Precision Medicine Clinical Trial Using Low-Dose Ondansetron (a 5-HT3 Antagonist) to Treat Alcohol Use Disorder;2023-07-06

4. Mifepristone as a pharmacological intervention for stress‐induced alcohol craving: A human laboratory study;Addiction Biology;2023-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3